These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36729117)

  • 1. Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
    Skowronski DM; Chuang ES; Sabaiduc S; Kaweski SE; Kim S; Dickinson JA; Olsha R; Gubbay JB; Zelyas N; Charest H; Bastien N; Jassem AN; De Serres G
    Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada.
    Kim S; Chuang ES; Sabaiduc S; Olsha R; Kaweski SE; Zelyas N; Gubbay JB; Jassem AN; Charest H; De Serres G; Dickinson JA; Skowronski DM
    Euro Surveill; 2022 Sep; 27(38):. PubMed ID: 36148674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    Skowronski DM; Leir S; Sabaiduc S; Chambers C; Zou M; Rose C; Olsha R; Dickinson JA; Winter AL; Jassem A; Gubbay JB; Drews SJ; Charest H; Chan T; Hickman R; Bastien N; Li Y; Krajden M; De Serres G
    J Infect Dis; 2022 Apr; 225(8):1387-1398. PubMed ID: 32215564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN).
    Skowronski DM; Zhan Y; Kaweski SE; Sabaiduc S; Khalid A; Olsha R; Carazo S; Dickinson JA; Mather RG; Charest H; Jassem AN; Levade I; Hasso M; Zelyas N; Gao R; Bastien N
    Euro Surveill; 2024 Feb; 29(7):. PubMed ID: 38362622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
    Kissling E; Pozo F; Buda S; Vilcu AM; Gherasim A; Brytting M; Domegan L; Gómez V; Meijer A; Lazar M; Vučina VV; Dürrwald R; van der Werf S; Larrauri A; Enkirch T; O'Donnell J; Guiomar R; Hooiveld M; Petrović G; Stoian E; Penttinen P; Valenciano M;
    Euro Surveill; 2019 Nov; 24(48):. PubMed ID: 31796152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Krajden M; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Kwindt TL; Bastien N; Li Y
    Clin Infect Dis; 2016 Jul; 63(1):21-32. PubMed ID: 27025838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.
    Skowronski DM; Chambers C; De Serres G; Dickinson JA; Winter AL; Hickman R; Chan T; Jassem AN; Drews SJ; Charest H; Gubbay JB; Bastien N; Li Y; Krajden M
    Euro Surveill; 2018 Feb; 23(5):. PubMed ID: 29409570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Price AM; Flannery B; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Mutnal M; Geffel KM; Nowalk MP; Tartof SY; Florea A; McLean C; Kim SS; Patel MM; Chung JR
    Clin Infect Dis; 2023 Apr; 76(8):1358-1363. PubMed ID: 36504336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
    Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
    J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
    Skowronski DM; Chambers C; Sabaiduc S; Dickinson JA; Winter AL; De Serres G; Drews SJ; Jassem A; Gubbay JB; Charest H; Balshaw R; Bastien N; Li Y; Krajden M
    Euro Surveill; 2017 Feb; 22(6):. PubMed ID: 28205503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
    Kissling E; Pozo F; Martínez-Baz I; Buda S; Vilcu AM; Domegan L; Mazagatos C; Dijkstra F; Latorre-Margalef N; Kurečić Filipović S; Machado A; Lazar M; Casado I; Dürrwald R; van der Werf S; O'Donnell J; Linares Dopido JA; Meijer A; Riess M; Višekruna Vučina V; Rodrigues AP; Mihai ME; Castilla J; Goerlitz L; Falchi A; Connell J; Castrillejo D; Hooiveld M; Carnahan A; Ilić M; Guiomar R; Ivanciuc A; Maurel M; Omokanye A; Valenciano M;
    Influenza Other Respir Viruses; 2023 Jan; 17(1):e13069. PubMed ID: 36702797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
    Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
    J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
    Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
    PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Melidou A; Hungnes O; Pereyaslov D; Adlhoch C; Segaloff H; Robesyn E; Penttinen P; Olsen SJ;
    Vaccine; 2020 Jul; 38(35):5707-5717. PubMed ID: 32624252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterisation of the influenza viruses circulating in Bulgaria during the 2019-2020 winter season.
    Korsun N; Trifonova I; Voleva S; Grigorova I; Angelova S
    Virus Genes; 2021 Oct; 57(5):401-412. PubMed ID: 34156583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Lewis NM; Zhu Y; Peltan ID; Gaglani M; McNeal T; Ghamande S; Steingrub JS; Shapiro NI; Duggal A; Bender WS; Taghizadeh L; Brown SM; Hager DN; Gong MN; Mohamed A; Exline MC; Khan A; Wilson JG; Qadir N; Chang SY; Ginde AA; Mohr NM; Mallow C; Lauring AS; Johnson NJ; Gibbs KW; Kwon JH; Columbus C; Gottlieb RL; Raver C; Vaughn IA; Ramesh M; Johnson C; Lamerato L; Safdar B; Casey JD; Rice TW; Halasa N; Chappell JD; Grijalva CG; Talbot HK; Baughman A; Womack KN; Swan SA; Harker E; Price A; DeCuir J; Surie D; Ellington S; Self WH;
    Clin Infect Dis; 2024 Apr; 78(4):1056-1064. PubMed ID: 38051664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.